Oppenheimer & Co Inc, the underwriter, exercised its over-allotment option and purchased an additional 1,050,000 shares, resulting in a total of 8,050,000 shares sold at USD2.85 per share.
Conexant will use the proceeds for general corporate purposes, including repaying, redeeming or repurchasing existing debt, as well as for working capital, capital expenditures and acquisitions.
Comments on this story may be sent to admin@m2.com

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index